Cannabinoids Part I - Legal policies and physiological effects

Drug Testing and Analysis

Volumn 5, Issue 1, 2013, Pages 20-21

  Kerwin, Jim ^a  

^a Kerwin Benchaar Consulting   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOIDS; PHYSIOLOGICAL EFFECTS; POLICY EFFECTS;

ALCOHOL; BENZODIAZEPINE; CANNABIDIOL; CANNABINOID; CANNABINOID RECEPTOR; CANNABIS; DOPAMINE; ENDOCANNABINOID; ILLICIT DRUG; SEROTONIN RECEPTOR; TETRAHYDROCANNABINOL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALZHEIMER DISEASE; ANENCEPHALUS; ATTENTION; ATTENTION DEFICIT DISORDER; CANNABIS ADDICTION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; CHRONIC PAIN; DETOXIFICATION; DOPAMINE RELEASE; DRUG ABUSE; DRUG EXPOSURE; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; EDITORIAL; EPIDEMIOLOGY; GESTATIONAL AGE; HUMAN; IMMUNE SYSTEM; LEGAL ASPECT; MEMORY DISORDER; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEUS ACCUMBENS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PREGNANCY; PREGNANT WOMAN; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; RESPONSE TIME; SCHIZOPHRENIA; SPICE; WASTING SYNDROME;

EID: 84872138604     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1440     Document Type: Editorial

References (14)

1. R. Mechoulam, L. Hanus A historical overview of chemical research on cannabinoids. Chem. Phys. Lipids 2000, 108, 1.
2. Y. Gaoni, R. Mechoulam Isolation, structure and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc. 1964, 86, 1646.
3. D.J. Harvey, W.D.M. Paton Metabolism of the cannabinoids. Rev. Biochem. Toxicol. 1984, 6, 221.
4. W.L. Dewey Cannabinoid pharmacology. Pharmacol. Rev. 1986, 38, 151.
5. L.A. Matsuda, S.J. Lolait, M.J. Brownstein, A.C. Young, T.I. Bonner Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990, 346, 561.
6. S. Munro, K.L. Thomas, M. Abu-Shaar Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993, 365, 61.
7. J.-P. Gong, E.S. Onaivi, H. Ishiguro, Q.-R. Liu, P.A. Agliaferro, A. Brusco, et al. Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain. Brain Res. 2006, 1071, 10.
8. J.M. Bostwick Blurrred boundaries: The therapeutics and politics of medical marijuana. Mayo Clin. Proc. 2012, 87, 172.
9. G.C. Loewinger, E.B. Oleson, J.F. Cheer Using dopamine research to generate rational cannabinoid drug policy. Drug Test. Anal. 2013, 5, 22.
10. D. Psychoyos, K Yaragudri Vinod Marijuana, Spice 'herbal high', and early neural development: implications for rescheduling and legalization. Drug Test. Anal. 2013, 5, 27.
11. S. Deiana Medical use of cannabis. Cannabidiol: A new light for schizophrenia? Drug Test. Anal. 2013, 5, 46.
12. P. Armentano Cannabis and psychomotor performance: A rational review of the evidence and implications for public policy. Drug Test. Anal. 2013, 5, 52.
13. L. Fattore Considering gender in cannabinoid research: A step towards personalized treatment of marijuana addicts. Drug Test. Anal. 2013, 5, 57.
14. E.L. Sevigny Is today's marijuana more potent simply because it's fresher? Drug Test. Anal. 2013, 5, 62.